Citation Impact
Citing Papers
Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)
2001 StandoutScience
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
Comparison of the high-resolution structures of the α-amylase inhibitor tendamistat determined by nuclear magnetic resonance in solution and by X-ray diffraction in single crystals
1989 StandoutNobel
Vasopressin-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting duct cells is mediated by the oxytocin receptor.
1991
Molecular cloning and functional characterization of V2 [8‐lysine] vasopressin and oxytocin receptors from a pig kidney cell line
1993
Molecular neurobiology and pharmacology of the Vasopressin/Oxytocin receptor family
1995
LDL subfractions and atherogenicity: An hypothesis from the University of Glasgow
1996
Regulation of V2 Vasopressin Receptor Degradation by Agonist-promoted Ubiquitination
2003 StandoutNobel
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Automated synthesis of oligosaccharides as a basis for drug discovery
2005
Siderophores as drug delivery agents: application of the “Trojan Horse” strategy
2009
The metabolic syndrome
2010 Standout
Glycosylation in Cellular Mechanisms of Health and Disease
2006 Standout
A Strategy for Functional Proteomic Analysis of Glycosidase Activity from Cell Lysates
2004 StandoutNobel
Metabolic origins and clinical significance of LDL heterogeneity
2002
Solubilization of oxytocin receptors in porcine renal LLC-PK1 cell membranes
1996
Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAP
1996
Carbohydrate mimetics-based glycosyltransferase inhibitors
2001
The metabolic syndrome
2005 Standout
Design, synthesis, and biological evaluation of isocyanurate-based antifungal and macrolide antibiotic conjugates: Iron transport-mediated drug delivery
1995
The growing impact of click chemistry on drug discovery
2003 StandoutNobel
Metabolic Delivery of Ketone Groups to Sialic Acid Residues
1998 StandoutNobel
Iron transport-mediated drug delivery using mixed-ligand siderophore-β-lactam conjugates
1996
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
2004 StandoutNature
Determination of the complete three-dimensional structure of the α-amylase inhibitor tendamistat in aqueous solution by nuclear magnetic resonance and distance geometry
1988 StandoutNobel
Inhibitors of protein glycosylation and glycoprotein processing in viral systems
1987
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
From carbohydrate leads to glycomimetic drugs
2009
New strategy for discovery of enzyme inhibitors: Screening with intact mammalian cells or intact microorganisms having special functions.
1990 StandoutNobel
Inflammation in atherosclerosis
2002 StandoutNature
Controlled reduction of acarbose: conformational analysis of acarbose and the resulting saturated products
1991 StandoutNobel
The TonB‐dependent ferrichrome receptor FcuA of Yersinia enterocolitica: evidence against a strict co‐evolution of receptor structure and substrate specificity
1993
Effect of cerivastatin sodium, a new inhibitor of HMG‐CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits
1999
Influence of Oxytocin on Renal Hemodynamics and Sodium Excretiona
1993
Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor
1991
Chemistry and biology of siderophores
2010 Standout
Synthesis of “dihydroacarbose”, an α-d-glucosidase inhibitor having a pseudo-tetrasaccharide structure
1989
Crystal structure of the antibiotic albomycin in complex with the outer membrane transporter FhuA
2000
Synthesis and characterization of the Zn(II) and Cu(II) piperidinyl isoeuxanthone complexes: DNA-binding and cytotoxic activity
2009
Asymmetric 1,3-Dipolar Cycloaddition Reactions
1998 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Early steps in processing of yeast glycoproteins.
1984 StandoutNobel
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Glucosidase inhibition
1977
The 5-Endo-trig Cyclization of D-Glucose Derived γ-Alkenylamines with Mercury (II) Salts: Synthesis of 1-Deoxycastanospermine and its 8a-epi-Analogue†
2005
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
A Potent and Highly Selective Inhibitor of Human α-1,3-Fucosyltransferase via Click Chemistry
2003 StandoutNobel
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
1998 StandoutScience
Comprehensive Survey of Combinatorial Library Synthesis: 2002
2003
Chemical Glycobiology
2001 StandoutScienceNobel
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
1998
Secondary structure of the α-amylase polypeptide inhibitor Tendamistat from Streptomyces tendae determined in solution by 1H nuclear magnetic resonance
1985 StandoutNobel
Inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases.
1982
Active transport of siderophore-mimicking antibacterials across the outer membrane
1999
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
1992 StandoutScience
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man.
1983 StandoutNobel
Albomycin Uptake via a Ferric Hydroxamate Transport System ofStreptococcus pneumoniaeR6
2006
Synthesis and Conformational and Biological Aspects of Carbasugars
2007
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery Disease
2005
Vasopressin induces V1 receptors to activate phosphatidylinositol- and phosphatidylcholine-specific phospholipase C and stimulates the release of arachidonic acid by at least two pathways in the smooth muscle cell line, A-10.
1988
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Oxytocin receptors on cultured astroglial cells. Regulation by a guanine-nucleotide-binding protein and effect of Mg2+
1992
Inflammation and Atherosclerosis
2002 Standout
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Utilization of L-serine in an oxime olefin cycloaddition route to a functionalized asymmetric pyrrolidine, a selective α-glucosidase inhibitor
1994
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro
2001
2-Deoxy-2-fluoro-D-glycosyl fluorides. A new class of specific mechanism-based glycosidase inhibitors.
1988
Antitumor Activity and DNA-Binding Investigations of the Zn(II) and Cu(II) Complexes with Isoeuxanthone
2009
Fluorine in medicinal chemistry: Recent therapeutic applications of fluorinated small molecules
2006 Standout
1-deoxynojirimycin impairs oligosaccharide processing of alpha 1-proteinase inhibitor and inhibits its secretion in primary cultures of rat hepatocytes.
1983
Diastereoselective Allylation of Carbonyl Compounds and Imines: Application to the Synthesis of Natural Products
2013 Standout
Evidence of two steps in the homologous desensitization of vasopressin-sensitive phospholipase C in WRK1 cells. Uncoupling and loss of vasopressin receptors.
1988
Siderophore-Based Iron Acquisition and Pathogen Control
2007 Standout
Investigating Cellular Metabolism of Synthetic Azidosugars with the Staudinger Ligation
2002 StandoutNobel
Efficient preparation of enantiomerically pure cyclic aminoalditols, total synthesis of 1-deoxynojirimycin and 1-deoxymannojirimycyn
1985
Iron Metabolism in Pathogenic Bacteria
2000
Isolation and structure elucidation of an α‐amylase inhibitor, AI‐3688, from Streptomyces aureofaciens
1985
In vitro generation of antigen-specific hemolytic plaque-forming cells from human peripheral blood mononuclear cells.
1981
Tendamistat (HOE 467), a tight-binding alpha-amylase inhibitor from Streptomyces tendae 4158. Isolation, biochemical properties
1984
INHIBITORS OF THE BIOSYNTHESIS AND PROCESSING OF N-LINKED OLIGOSACCHARIDE CHAINS
1987
Salmycin A–D, Antibiotika aus Streptomyces violaceus, DSM 8286, mit Siderophor‐Aminoglycosid‐Struktur
1995
Advances in Copper Complexes as Anticancer Agents
2013 Standout
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Enzyme-catalyzed synthesis of carbohydrates
1989
Prepro-alpha-factor has a cleavable signal sequence.
1988 StandoutNobel
Isolation of glucose-containing high-mannose glycoprotein core oligosaccharides.
1984 StandoutNobel
Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors.
1990
Crystal structure determination, refinement and the molecular model of the α-amylase inhibitor Hoe-467A
1986 StandoutNobel
Enzyme Responsive Nanocontainers with Cyclodextrin Gatekeepers and Synergistic Effects in Release of Guests
2009
Studies by 1H nuclear magnetic resonance and distance geometry of the solution conformation of the α-amylase inhibitor Tendamistat
1986 StandoutNobel
Pathophysiology and Pharmacological Treatment of Insulin Resistance*
2000
The solution conformation of acarbose
1984
Mechanized Silica Nanoparticles: A New Frontier in Theranostic Nanomedicine
2011 StandoutNobel
Complete sequence-specific 1H nuclear magnetic resonance assignments for the α-amylase polypeptide inhibitor tendamistat from Streptomyces tendae
1986 StandoutNobel
Synthesis, Biological Activity, and Molecular Modeling Studies of 1H-1,2,3-Triazole Derivatives of Carbohydrates as α-Glucosidases Inhibitors
2010
Works of Delf Schmidt being referenced
Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein
1995
Preclinical review of cerivastatin sodium—a step forward in HMG-CoA reductase inhibition
1998
Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor
1997
Biphenyls as potent vitronectin receptor antagonists
2002
Identification and characterization of vascular (V1) vasopressin receptors of an established smooth muscle cell line.
1987
Konstitution der Desferriform der Albomycine ?1, ?2, ?
1982
Albomycine, IV. Isolierung und Totalsynthese von (N5‐Acetyl‐N5‐hydroxy‐L ‐ornithyl)‐(N5‐acetyl‐N5‐hydroxy‐L ‐ornithyl)‐N5‐acetyl‐N5‐hydroxy‐L ‐ornithin
1984
Fluorine-Substitution in Cholesteryl Ester Transfer Protein Inhibitors (CETPInhibitors) – Biology, Chemistry, SAR, and Properties
2004
A novel radiolabeled vasopressin antagonist: [3H-Phe]-desGlyd(CH2)5D-Tyr(Et)VAVP, [3H]-SK&F 101926.
1987
Chemistry and Biochemistry of Microbial α‐Glucosidase Inhibitors
1981
Constitution of the Deferriform of the Albomycins δ1, δ2 and ε
1982
Chemie und Biochemie mikrobieller α‐Glucosidasen‐Inhibitoren
1981
Glucosidase-Inhibitoren aus Bazillen
1979
Konstitution der Desferriform der Albomycine δ1, δ2 und ε
1982
Production of Antibody to Sheep Red Blood Cells by Human Tonsil Cells in vitro
1973 Nature
?-Glucosidase inhibitors
1977
Untersuchungen zur struktur des α-d-glucosidaseinhibitors acarbose
1984
Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
1988